期刊簡介預計審稿時間： 偏慢,4-8周

Manuscripts of original studies reinforcing the evidence base of modern diagnostic pathology, using immunocytochemical, molecular and ultrastructural techniques, will be welcomed. In addition, papers on critical evaluation of diagnostic criteria but also broadsheets and guidelines with a solid evidence base will be considered. Consideration will also be given to reports of work in other fields relevant to the understanding of human pathology as well as manuscripts on the application of new methods and techniques in pathology. Submission of purely experimental articles is discouraged but manuscripts on experimental work applicable to diagnostic pathology are welcomed. Biomarker studies are welcomed but need to abide by strict rules (e.g. REMARK) of adequate sample size and relevant marker choice. Single marker studies on limited patient series without validated application will as a rule not be considered. Case reports will only be considered when they provide substantial new information with an impact on understanding disease or diagnostic practice.

歡迎使用免疫細胞化學、分子和超微結構技術來強化現(xiàn)代診斷病理學證據(jù)基礎的原創(chuàng)研究手稿。此外，還將考慮關于診斷標準的批判性評估以及具有堅實證據(jù)基礎的宣傳單和指南的論文。還將考慮與理解人類病理學相關的其他領域的工作報告以及關于在病理學中應用新方法和技術的手稿。不鼓勵提交純實驗性文章，但歡迎提交適用于診斷病理學的實驗性工作手稿。歡迎生物標志物研究，但需要遵守足夠的樣本量和相關標志物選擇的嚴格規(guī)則（例如 REMARK）。沒有經(jīng)過驗證的應用的有限患者系列的單一標志物研究通常不予考慮。只有當病例報告提供大量新信息并對理解疾病或診斷實踐產生影響時，才會考慮它們。

《Virchows Archiv》(Virchow的檔案)編輯部通訊方式為SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013。如果您需要協(xié)助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發(fā)表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節(jié)省您的寶貴時間，有效提升發(fā)表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內容。